Related Experiment Video
Updated: Aug 22, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic
Ray Y Hachem1, Dimitrios P Kontoyiannis, Maha R Boktour
1Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston 77030, USA. rhachem@mdanderson.org
Background:
Invasive aspergillosis (IA) has emerged as a common cause of morbidity and mortality among immunocompromised patients. At The University of Texas M. D. Anderson Cancer Center (Houston, TX), Aspergillus terreus is second to A. fumigatus as the most common cause of IA. In the current study, the authors compared the risk factors and outcomes associated with IA caused by A. terreus and IA caused by A. fumigatus.
Methods:
The authors retrospectively reviewed the medical records of 300 patients who received care at our institution between 1995 and 2001 and who had cultures that were positive for Aspergillus infection, including 90 patients whose cultures were positive for A. fumigatus and 70 patients whose cultures were positive for A. terreus.
Results:
Thirty-two patients with IA caused by A. terreus and 33 patients with IA caused by A. fumigatus were evaluated. The two groups were comparable in terms of age, gender, and underlying disease. Leukemia was the most common underlying malignancy (84%). More than 40% of patients in each group had undergone bone marrow transplantation. There was a trend toward a higher frequency of neutropenia among patients with IA caused by A. terreus (P = 0.12). IA caused by A. terreus was considered to be nosocomial in origin significantly more frequently compared with IA caused by A. fumigatus (P = 0.03). In vitro, A. terreus was found to be more resistant to amphotericin B (minimal inhibitory concentration [MIC90], 4.0 microg/mL) than to antifungal therapy (MIC90, 1.0 Hg/mL) in the isolates that were tested (< 50% of all isolates). The overall rate of response to antifungal therapy was 39% for patients with A. fumigatus infection, compared with 28% for patients with A. terreus infection (P = 0.43).
Conclusions:
Despite the decreased in vitro susceptibility of A. terreus (relative to A. fumigatus) to amphotericin B, the two groups within the current patient population had comparably poor responses to amphotericin B preparation and somewhat improved responses to posaconazole.
Insights
Invasive aspergillosis (IA) caused by Aspergillus terreus and Aspergillus fumigatus have similar poor outcomes in immunocompromised patients. Aspergillus terreus IA was more frequently nosocomial and showed reduced susceptibility to amphotericin B.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Invasive aspergillosis (IA) is a significant cause of mortality in immunocompromised individuals.
- Aspergillus terreus is the second most common cause of IA at The University of Texas M. D. Anderson Cancer Center, after Aspergillus fumigatus.
- This study compares risk factors and outcomes of IA caused by A. terreus versus A. fumigatus.
Purpose of the Study:
- To compare the risk factors and clinical outcomes of invasive aspergillosis (IA) caused by Aspergillus terreus and Aspergillus fumigatus.
- To evaluate the antifungal susceptibility patterns of A. terreus and A. fumigatus isolates.
- To assess patient response to antifungal therapies.
Main Methods:
- Retrospective review of medical records for 300 patients with Aspergillus infection (1995-2001).
- Specific analysis of 32 patients with A. terreus IA and 33 patients with A. fumigatus IA.
- In vitro antifungal susceptibility testing, including minimal inhibitory concentrations (MICs).
Main Results:
- Patient groups with A. terreus and A. fumigatus IA were comparable in age, gender, and underlying disease (leukemia most common).
- A trend towards higher neutropenia frequency was observed in the A. terreus group.
- IA caused by A. terreus was significantly more frequent in nosocomial infections (P=0.03) and showed higher resistance to amphotericin B (MIC90, 4.0 µg/mL).
Conclusions:
- Despite decreased in vitro susceptibility to amphotericin B, A. terreus and A. fumigatus IA showed comparably poor responses to amphotericin B.
- Both IA types demonstrated somewhat improved responses to posaconazole.
- A. terreus IA was more frequently associated with nosocomial acquisition.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Candidiasis
Fungal Phylum Microsporidia
